Role of Visfatin in Restoration of Ovarian Aging and Fertility in the Mouse Aged 18 Months
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q1
- 저널
- REPRODUCTIVE SCIENCES27(2) · pp.681 · 2020
- 피인용
- Web of Science 18Scopus 19
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2019 2.616
- ISSN
- 1933-7191
저자
- 박병규제1저자Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Gudeok-Ro 187, Seo-Gu, Busan, 49241, Republic of Korea
- Park, Min JungThe Korea Institute for Public Sperm Bank, Busan, Republic of Korea
- 김휘곤Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Gudeok-Ro 187, Seo-Gu, Busan, 49241, Republic of Korea
- 한시은Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Gudeok-Ro 187, Seo-Gu, Busan, 49241, Republic of Korea
- Kim, Chang-WoonDepartment of Obstetrics and Gynecology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea
- 주보선The Korea Institute for Public Sperm Bank, Busan, Republic of Korea
- 이규섭교신저자Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Gudeok-Ro 187, Seo-Gu, Busan, 49241, Republic of Korea
초록
The activation of dormant primordial follicles and ovarian angiogenesis has been attempted as a new treatment strategy for age-related ovarian aging. This study examined whether visfatin rescues age-related fertility decline in female mice aged 18 months, and whether this effect relates to the mTOR/PI3K signaling pathways for activation of primordial follicles and ovarian angiogenesis. Female mice were intraperitoneally injected with 0.1 ml of 500 ng/ml or 1000 ng/ml of visfatin three times at intervals of 2 days, and both ovaries were provided for H&E staining. In another experiment, the mice were superovulated with pregnant mare's serum gonadotropin and human chorionic gonadotropin, and were mated with males. After 18 h, zygotes were collected and cultured for 4 days, and numbers and embryo developmental competency of zygotes retrieved were evaluated. The expression of mTOR/PI3K signaling pathway regulated genes (4EBP1, S6K1, and RPS6) and angiogenic factors (VEGF, visfatin, and SDF-1 alpha) in the ovary were examined. As well, visfatin-treated mice were mated with male mice for 2 weeks, and the pregnancy outcome was monitored up to 3 weeks. Visfatin significantly increased the total numbers of follicles compared with control. Numbers of zygotes retrieved, blastocyst formation rate, and pregnancy rate were significantly increased at 500 ng/ml of visfatin (2.83%, 40.0%, and 80%, respectively) compared with control (0, 0, and no pregnancy). Ovarian expressions of S6K1, RPS6, VEGF, visfatin, and SDF-1 alpha were significantly stimulated at 500 ng/ml of visfatin. These results show that visfatin treatment of an optimal dose rescues age-related decline in fertility, possibly by stimulating mTOR/PI3K signaling.
키워드
VisfatinOvarian agingFertilityPrimordial follicle activationmTORPI3KENDOTHELIAL GROWTH-FACTORDEVELOPMENTAL COMPETENCEFOLLICULAR DEVELOPMENTACTIVATIONFOLLICLESEXPRESSIONOOCYTESmTOR/PI3K
식별자
- Scopus EID
- 2-s2.0-85079804095
- WoS UID
- 000525433100027



로그인
연구물 목록으로